·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊÆ÷ÀÎÆ®¸ôTVÆʵµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ º¸·É, °íÇ÷¾Ð-°íÁöÇ÷Áõ 3Á¦ º¹ÇÕÁ¦ 'µàÄ«·ÎÁ¤' Çã°¡ ±â»çÀÔ·Â : 19.11.13 18:47:34 0 °¡ ÇÃÄ£Ãß°¡ ÇǸ¶»ç¸£Åº-¾Ï·ÎµðÇÉ-·Î¼ö¹Ù½ºÅ¸Æ¾ °áÇÕ¡¦6³â°£ Àç½É»ç´ë»ó ÁöÁ¤ [µ¥Àϸ®ÆÊ=ÀÌŹ¼ø ±âÀÚ] º¸·ÉÁ¦¾àÀÌ °íÇ÷¾ÐÄ¡·áÁ¦ 2°³ ¼ººÐ°ú °íÁöÇ÷ÁõÄ¡·áÁ¦ '½ºÅ¸Æ¾' ¼ººÐÀÌ °áÇÕµÈ 3Á¦ º¹ÇÕÁ¦ 'µàÄ«·ÎÁ¤'À» Çã°¡¹Þ¾Ò´Ù. ½Ä¾àó´Â 13ÀÏ µàÄ«·ÎÁ¤ 5°³ ¿ë·®(30/5/10mg, 30/5/5mg, 60/10/20mg, 60/5/10mg, 60/5/5mg) Ç°¸ñÀ» ½ÃÆÇ ½ÂÀÎÇß´Ù. µàÄ«·ÎÁ¤Àº º¸·ÉÁ¦¾àÀÇ °£ÆÇ ARB °è¿ °íÇ÷¾ÐÄ¡·áÁ¦ Ä«³ªºêÀÇ ¼ººÐÀÎ 'ÇǸ¶»ç¸£ÅºÄ®·ý'°ú CCB °è¿ '¾Ï·ÎµðÇɺ£½Ç»ê¿°', °íÁöÇ÷ÁõÄ¡·áÁ¦ ¼ººÐÀÎ '·Î¼ö¹Ù½ºÅ¸Æ¾Ä®½·'ÀÌ °áÇÕµÈ º¹ÇÕÁ¦·Î, ÇǸ¶»ç¸£Åº/¾Ï·ÎµðÇÉ º¹ÇÕÁ¦¿Í ·Î¼ö¹Ù½ºÅ¸Æ¾À» µ¿½Ã¿¡ Åõ¿©ÇØ¾ß Çϴ ȯÀÚ¿¡ »ç¿ëÇϵµ·Ï Çã°¡µÆ´Ù. ÀÚ·áÁ¦ÃâÀǾàÇ°À¸·Î, 2025³â 11¿ù 12ÀϱîÁö 6³â°£ Àç½É»ç´ë»ó¿¡ ÁöÁ¤µÆ´Ù. ÇǸ¶»ç¸£Åº°ú ¾Ï·ÎµðÇÉ º¹ÇÕÁ¦´Â 'µàÄ«ºê'´Ù. ÃÖ±Ù ±¹³»¿¡¼ ARB-CCB-½ºÅ¸Æ¾ÀÌ °áÇÕµÈ 3Á¦ º¹ÇÕÁ¦°¡ ´Ã°í ÀÖ´Ù. ´ëÇ¥ÀûÀÎ Ç°¸ñÀ¸·Î Çѹ̾àÇ° '¾Æ¸ðÀßźť'°¡ ÀÖ´Ù. ÀÌŹ¼ø ±âÀÚ(hooggasi2@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç [ÇÏ¿ìÅõ¾à] ºê·£µå/Ç÷§Æû ¿î¿µ Àü·« ±âȹ ¾à»ç ÀÎÅÏ ¸ðÁý ¹Ù·Î°¡±â ¿µ¾÷ / training / compliance / admin ¹Ù·Î°¡±â Market Access Manager ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à»ç ä¿ë(Çѱ¹ÀǾàÇ°¾ÈÀü°ü¸®¿ø 24³â 3Â÷ ä¿ë) ¹Ù·Î°¡±â ¿ø·áÀǾàÇ° µµ¸Å, ¼öÀÔ°ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â MSL GM CVT (À°¾ÆÈÞÁ÷´ëü 1³â °è¾àÁ÷) ¹Ù·Î°¡±â [Çѱ¹¿ÀÃ÷Ä«Á¦¾à] Clinical Trial Manager(1~3»ó) ¹Ù·Î°¡±â [»ï¿ø¾àÇ° ¿ï»êÁöÁ¡] °ü¸®¾à»ç´Ô ¸ðÁý°ø°í ¹Ù·Î°¡±â PV ±×·ì ¹× ½Ã¼³±×·ì ä¿ë ¹Ù·Î°¡±â 2024 ¾à´ë½ÉȽǽÀ, Àü¹®¿¬±¸¿ä¿ø ¸ðÁý ¹Ù·Î°¡±â ȯÀÎÁ¦¾à(ÁÖ) 5¿ù ¼ö½Ãä¿ë(5/7(¿ù)~5/27(¿ù) 13:30±îÁö) ¹Ù·Î°¡±â [ºñŸ¹ÎÇϿ콺] ¾à»ç °æ·ÂÁ÷ ä¿ë ¹Ù·Î°¡±â Sr. Medical Affairs Scientist ¹Ù·Î°¡±â RA, BD, ¿µ¾÷, °øÀå µî ÀüºÎ¹® ä¿ë ¹Ù·Î°¡±â Sr. Clinical Operations Manager ¹Ù·Î°¡±â (´ëÀü/Ãæû) ¿µ¾÷ºÎ °æ·ÂÁ÷(ÁÖÀÓ~´ë¸®±Þ) ¸ðÁý ¹Ù·Î°¡±â MSL Radiology ¹Ù·Î°¡±â º¹»ê³ªÀ̽º ºÎ»ê°ü¸®¾à»ç (ºÎ»êÅëÇÕ¹°·ù¼¾ÅÍ) ¹Ù·Î°¡±â [¾Ëº¸Á¨ÄÚ¸®¾Æ] Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : º¸·É, °íÇ÷¾Ð-°íÁöÇ÷Áõ 3Á¦ º¹ÇÕÁ¦ µàÄ«·ÎÁ¤ Çã°¡ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ º¸·É, °íÇ÷¾Ð-°íÁöÇ÷Áõ 3Á¦ º¹ÇÕÁ¦ 'µàÄ«·ÎÁ¤' Çã°¡ ±â»çÀÔ·Â : 19.11.13 18:47:34 0 °¡ ÇÃÄ£Ãß°¡ ÇǸ¶»ç¸£Åº-¾Ï·ÎµðÇÉ-·Î¼ö¹Ù½ºÅ¸Æ¾ °áÇÕ¡¦6³â°£ Àç½É»ç´ë»ó ÁöÁ¤ [µ¥Àϸ®ÆÊ=ÀÌŹ¼ø ±âÀÚ] º¸·ÉÁ¦¾àÀÌ °íÇ÷¾ÐÄ¡·áÁ¦ 2°³ ¼ººÐ°ú °íÁöÇ÷ÁõÄ¡·áÁ¦ '½ºÅ¸Æ¾' ¼ººÐÀÌ °áÇÕµÈ 3Á¦ º¹ÇÕÁ¦ 'µàÄ«·ÎÁ¤'À» Çã°¡¹Þ¾Ò´Ù. ½Ä¾àó´Â 13ÀÏ µàÄ«·ÎÁ¤ 5°³ ¿ë·®(30/5/10mg, 30/5/5mg, 60/10/20mg, 60/5/10mg, 60/5/5mg) Ç°¸ñÀ» ½ÃÆÇ ½ÂÀÎÇß´Ù. µàÄ«·ÎÁ¤Àº º¸·ÉÁ¦¾àÀÇ °£ÆÇ ARB °è¿ °íÇ÷¾ÐÄ¡·áÁ¦ Ä«³ªºêÀÇ ¼ººÐÀÎ 'ÇǸ¶»ç¸£ÅºÄ®·ý'°ú CCB °è¿ '¾Ï·ÎµðÇɺ£½Ç»ê¿°', °íÁöÇ÷ÁõÄ¡·áÁ¦ ¼ººÐÀÎ '·Î¼ö¹Ù½ºÅ¸Æ¾Ä®½·'ÀÌ °áÇÕµÈ º¹ÇÕÁ¦·Î, ÇǸ¶»ç¸£Åº/¾Ï·ÎµðÇÉ º¹ÇÕÁ¦¿Í ·Î¼ö¹Ù½ºÅ¸Æ¾À» µ¿½Ã¿¡ Åõ¿©ÇØ¾ß Çϴ ȯÀÚ¿¡ »ç¿ëÇϵµ·Ï Çã°¡µÆ´Ù. ÀÚ·áÁ¦ÃâÀǾàÇ°À¸·Î, 2025³â 11¿ù 12ÀϱîÁö 6³â°£ Àç½É»ç´ë»ó¿¡ ÁöÁ¤µÆ´Ù. ÇǸ¶»ç¸£Åº°ú ¾Ï·ÎµðÇÉ º¹ÇÕÁ¦´Â 'µàÄ«ºê'´Ù. ÃÖ±Ù ±¹³»¿¡¼ ARB-CCB-½ºÅ¸Æ¾ÀÌ °áÇÕµÈ 3Á¦ º¹ÇÕÁ¦°¡ ´Ã°í ÀÖ´Ù. ´ëÇ¥ÀûÀÎ Ç°¸ñÀ¸·Î Çѹ̾àÇ° '¾Æ¸ðÀßźť'°¡ ÀÖ´Ù. ÀÌŹ¼ø ±âÀÚ(hooggasi2@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç [ÇÏ¿ìÅõ¾à] ºê·£µå/Ç÷§Æû ¿î¿µ Àü·« ±âȹ ¾à»ç ÀÎÅÏ ¸ðÁý ¹Ù·Î°¡±â ¿µ¾÷ / training / compliance / admin ¹Ù·Î°¡±â Market Access Manager ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à»ç ä¿ë(Çѱ¹ÀǾàÇ°¾ÈÀü°ü¸®¿ø 24³â 3Â÷ ä¿ë) ¹Ù·Î°¡±â ¿ø·áÀǾàÇ° µµ¸Å, ¼öÀÔ°ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â MSL GM CVT (À°¾ÆÈÞÁ÷´ëü 1³â °è¾àÁ÷) ¹Ù·Î°¡±â [Çѱ¹¿ÀÃ÷Ä«Á¦¾à] Clinical Trial Manager(1~3»ó) ¹Ù·Î°¡±â [»ï¿ø¾àÇ° ¿ï»êÁöÁ¡] °ü¸®¾à»ç´Ô ¸ðÁý°ø°í ¹Ù·Î°¡±â PV ±×·ì ¹× ½Ã¼³±×·ì ä¿ë ¹Ù·Î°¡±â 2024 ¾à´ë½ÉȽǽÀ, Àü¹®¿¬±¸¿ä¿ø ¸ðÁý ¹Ù·Î°¡±â ȯÀÎÁ¦¾à(ÁÖ) 5¿ù ¼ö½Ãä¿ë(5/7(¿ù)~5/27(¿ù) 13:30±îÁö) ¹Ù·Î°¡±â [ºñŸ¹ÎÇϿ콺] ¾à»ç °æ·ÂÁ÷ ä¿ë ¹Ù·Î°¡±â Sr. Medical Affairs Scientist ¹Ù·Î°¡±â RA, BD, ¿µ¾÷, °øÀå µî ÀüºÎ¹® ä¿ë ¹Ù·Î°¡±â Sr. Clinical Operations Manager ¹Ù·Î°¡±â (´ëÀü/Ãæû) ¿µ¾÷ºÎ °æ·ÂÁ÷(ÁÖÀÓ~´ë¸®±Þ) ¸ðÁý ¹Ù·Î°¡±â MSL Radiology ¹Ù·Î°¡±â º¹»ê³ªÀ̽º ºÎ»ê°ü¸®¾à»ç (ºÎ»êÅëÇÕ¹°·ù¼¾ÅÍ) ¹Ù·Î°¡±â [¾Ëº¸Á¨ÄÚ¸®¾Æ] Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : º¸·É, °íÇ÷¾Ð-°íÁöÇ÷Áõ 3Á¦ º¹ÇÕÁ¦ µàÄ«·ÎÁ¤ Çã°¡ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ º¸·É, °íÇ÷¾Ð-°íÁöÇ÷Áõ 3Á¦ º¹ÇÕÁ¦ 'µàÄ«·ÎÁ¤' Çã°¡ ±â»çÀÔ·Â : 19.11.13 18:47:34 0 °¡ ÇÃÄ£Ãß°¡ ÇǸ¶»ç¸£Åº-¾Ï·ÎµðÇÉ-·Î¼ö¹Ù½ºÅ¸Æ¾ °áÇÕ¡¦6³â°£ Àç½É»ç´ë»ó ÁöÁ¤ [µ¥Àϸ®ÆÊ=ÀÌŹ¼ø ±âÀÚ] º¸·ÉÁ¦¾àÀÌ °íÇ÷¾ÐÄ¡·áÁ¦ 2°³ ¼ººÐ°ú °íÁöÇ÷ÁõÄ¡·áÁ¦ '½ºÅ¸Æ¾' ¼ººÐÀÌ °áÇÕµÈ 3Á¦ º¹ÇÕÁ¦ 'µàÄ«·ÎÁ¤'À» Çã°¡¹Þ¾Ò´Ù. ½Ä¾àó´Â 13ÀÏ µàÄ«·ÎÁ¤ 5°³ ¿ë·®(30/5/10mg, 30/5/5mg, 60/10/20mg, 60/5/10mg, 60/5/5mg) Ç°¸ñÀ» ½ÃÆÇ ½ÂÀÎÇß´Ù. µàÄ«·ÎÁ¤Àº º¸·ÉÁ¦¾àÀÇ °£ÆÇ ARB °è¿ °íÇ÷¾ÐÄ¡·áÁ¦ Ä«³ªºêÀÇ ¼ººÐÀÎ 'ÇǸ¶»ç¸£ÅºÄ®·ý'°ú CCB °è¿ '¾Ï·ÎµðÇɺ£½Ç»ê¿°', °íÁöÇ÷ÁõÄ¡·áÁ¦ ¼ººÐÀÎ '·Î¼ö¹Ù½ºÅ¸Æ¾Ä®½·'ÀÌ °áÇÕµÈ º¹ÇÕÁ¦·Î, ÇǸ¶»ç¸£Åº/¾Ï·ÎµðÇÉ º¹ÇÕÁ¦¿Í ·Î¼ö¹Ù½ºÅ¸Æ¾À» µ¿½Ã¿¡ Åõ¿©ÇØ¾ß Çϴ ȯÀÚ¿¡ »ç¿ëÇϵµ·Ï Çã°¡µÆ´Ù. ÀÚ·áÁ¦ÃâÀǾàÇ°À¸·Î, 2025³â 11¿ù 12ÀϱîÁö 6³â°£ Àç½É»ç´ë»ó¿¡ ÁöÁ¤µÆ´Ù. ÇǸ¶»ç¸£Åº°ú ¾Ï·ÎµðÇÉ º¹ÇÕÁ¦´Â 'µàÄ«ºê'´Ù. ÃÖ±Ù ±¹³»¿¡¼ ARB-CCB-½ºÅ¸Æ¾ÀÌ °áÇÕµÈ 3Á¦ º¹ÇÕÁ¦°¡ ´Ã°í ÀÖ´Ù. ´ëÇ¥ÀûÀÎ Ç°¸ñÀ¸·Î Çѹ̾àÇ° '¾Æ¸ðÀßźť'°¡ ÀÖ´Ù. ÀÌŹ¼ø ±âÀÚ(hooggasi2@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : º¸·É, °íÇ÷¾Ð-°íÁöÇ÷Áõ 3Á¦ º¹ÇÕÁ¦ µàÄ«·ÎÁ¤ Çã°¡ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö